<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="130958">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01689077</url>
  </required_header>
  <id_info>
    <org_study_id>TTH48</org_study_id>
    <nct_id>NCT01689077</nct_id>
  </id_info>
  <brief_title>Time-differentiated Therapeutic Hypothermia</brief_title>
  <acronym>TTH48</acronym>
  <official_title>Time-differentiated Treatment With Mild Therapeutic Hypothermia Following Cardiac Arrest, a Multi Center Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if 48 hours of mild therapeutic hypothermia
      following out of hospital cardiac arrest gives a better cerebral outcome compared to 24
      hours therapeutic hypothermia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sudden out-of-hospital cardiac arrest (OOH-CA) remains a significant cause of death.
      However, in 2002 it was in two clinical trials demonstrated that mild therapeutic
      hypothermia in comatose OOH-CA victims yields a better cerebral outcome measured by Cerebral
      Performance Category Score (CPC) after 6 month. The optimal mild hypothermia treatment time
      is however not known. The two trials from 2002 apply the treatment for 12 and 24 hours
      respectively. In newborns with cerebral hypoxic damage the standard treatment time is 72
      hours. It is therefore relevant to investigate the influence of the treatment time on the
      cerebral outcome in OOH-CA victims. In the present study cerebral outcome after mild
      therapeutic hypothermia (target temperature 33 degrees centigrade) in OOH_CA patients for 24
      is compared to outcome after 48 hours of mild hypothermia. The main outcome parameter is
      mortality and CPC score measured 6 month after the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>CPC</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>CPC = Cerebral Performance Category Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Adverse events are registered during the treatment and the following 7 days</description>
  </secondary_outcome>
  <other_outcome>
    <measure>MMSE and ACE</measure>
    <time_frame>Day 4 and 6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Minimal Mental State Examination (MMSE) and Addenbrook's Cognitive Examination (ACE) are measured day four 4 and after 6 month</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Out of Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>24 hours hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>24 hours hypothermia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>48 hours hypothermoa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>48 hours hypothermia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Therapeutic hypothermia</intervention_name>
    <description>Mild therapeutic hypothermia with a target temperature of 33 degrees centigrade</description>
    <arm_group_label>24 hours hypothermia</arm_group_label>
    <arm_group_label>48 hours hypothermoa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Out of hospital cardiac arrest of suspected cardiac origion

          2. Return of spontaneous circulation (ROSC)

          3. Glasgow Coma Score &lt; 8

          4. Estimated time interval from cardiac arrest to ROSC ≤ 60 min

        Exclusion Criteria:

          1. OUH-CA of suspected origin other than cardiac

          2. In hospital Cardiac arrest

          3. Terminal disease

          4. Coagulation disorders

          5. Unwitnessed asystolia

          6. Time from cardiac arrest to start of hypothermia treatment &gt; 240 min

          7. GCS ≥ 8

          8. Pregnancy

          9. Persistent cardiogenic shock (Systolic blood pressure &lt; 80 mmHg despite inotropic
             treatment and aortic balloon pump).

         10. CPC 3-4 before cardiac arrest

         11. Acute intra cerebral bleeding

         12. Acute stroke

         13. Acute CABG
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Kirkegaard, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesia and Intensive care medicine, Aarhus University Hosptal, Brendstrupgaardsvej 8200 Aarhus, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hans Kirkegaard, Professor</last_name>
    <phone>004528149787</phone>
    <email>hanskirkegaard@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aalborg</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Inge De Haas, MD</last_name>
      <phone>004599328588</phone>
      <email>dehaas@dadlnet.dk</email>
    </contact>
    <investigator>
      <last_name>Inge De Haas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department og Anesthesiologi and Intensive Care Medicine,</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Kirkegaard, Professor</last_name>
      <phone>004528149783</phone>
      <email>hanskirkegaard@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Susanne Ilkjaer, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Susanne Ilkjaer, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Hassager, MD, DMSci</last_name>
      <email>hassager@dadlnet.dk</email>
    </contact>
    <investigator>
      <last_name>Christian Hassager, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henrik Schmidt, MD, DrMedSci</last_name>
      <phone>004565412411</phone>
      <email>henrik.schmidt@ouh.regionsyddammark.dk</email>
    </contact>
    <investigator>
      <last_name>Henrik Schmidt, MD, DrMedSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 13, 2013</lastchanged_date>
  <firstreceived_date>September 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
